Aethlon Medical Inc (AEMD)

[ANESRI]

So although the two new drugs are up for approval next month, it is not so much of a bad news for AEMD. Althogh the SVR are better compared to the current SOC, they are not where they can be with the HP as an adjunct i.e greater than 90% atleast.

Mutation of the virus may be a big thing. This may confer drug resistance. For the HP there is no issue of resistance!
Now this is just a theory of mine - more the virus more chance of mutation, so if the HP is used to bring the virus count to negligible levels then less chance of mutation and the drug can penetrate more.

Less effectiveness of the drug in African Americans - No issue with the HP in terms of race. Also, is the response in Asians any different? Asia also has its high share in terms of HCV infected people.

The new drugs have some side effects - the HP has been used extensively with minimal side effects as per the company.

HCV apprantely is a huge market and that is why people are excited to see new drugs coming in. But although they offer hope they still do not offer complete recovery round the board. That may a possibility with the HP